Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYS6006 in Chinese Adults With Hybrid Immunity
NCT07834073Phase 4Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- May 2023
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 4 trial of SYS6006 in coronavirus disease 2019 (COVID-19), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started May 2023; status: completed.
02
Drugs
SYS6006
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07834073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07834073.